Dr. Shailja Shah, MD

Dr. Shah practices at Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health.

Dr. Shah's NPI, 1487912044, was assigned on May 1, 2012. Dr. Shah holds Indiana license 01077843A.

Dr. Shah's primary practice is Newark Beth Israel Medical Center, at 201 Lyons Ave, Newark, NJ 07112 in Essex County. The practice phone is (973) 926-7000.

Dr. Shah's primary practice is Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Shah to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Shah's licenses on file in 2 states: Indiana and New Jersey.

CMS data shows 254 Medicare services from Dr. Shah across 4 procedure codes in 2024, for 64 Medicare patients. Medicare paid $18,897 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 68, with 64% women.

In 2024, Dr. Shah wrote 294 Medicare Part D claims for 61 patients. 77% of them were for generic drugs. CMS names the drug for 168 of them, across 8 drugs with 11 or more claims each, at $231,657 in total drug cost. In 2023, CMS named 105 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Shah for performance year 2024, reported through an alternative payment model (APM). Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 251 general payments to Dr. Shah from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Merck Sharp & Dohme Corporation paid the most, $516.